Prothena Corp PLC (PRTA)
48.75
+0.63 (+1.31%)
USD |
NASDAQ |
Mar 29, 11:53
Prothena Shareholders Equity (Quarterly): 622.04M for Dec. 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 622.04M |
| September 30, 2022 | 404.65M |
| June 30, 2022 | 407.30M |
| March 31, 2022 | 438.89M |
| December 31, 2021 | 466.04M |
| September 30, 2021 | 490.47M |
| June 30, 2021 | 288.21M |
| March 31, 2021 | 234.58M |
| December 31, 2020 | 184.01M |
| September 30, 2020 | 209.51M |
| June 30, 2020 | 234.44M |
| March 31, 2020 | 255.04M |
| December 31, 2019 | 272.92M |
| September 30, 2019 | 289.18M |
| June 30, 2019 | 302.81M |
| March 31, 2019 | 312.13M |
| December 31, 2018 | 323.00M |
| September 30, 2018 | 339.65M |
| June 30, 2018 | 356.01M |
| March 31, 2018 | 409.50M |
| December 31, 2017 | 407.19M |
| Date | Value |
|---|---|
| September 30, 2017 | 446.25M |
| June 30, 2017 | 486.98M |
| March 31, 2017 | 496.25M |
| December 31, 2016 | 365.40M |
| September 30, 2016 | 401.10M |
| June 30, 2016 | 430.86M |
| March 31, 2016 | 465.78M |
| December 31, 2015 | 360.67M |
| September 30, 2015 | 377.95M |
| June 30, 2015 | 395.22M |
| March 31, 2015 | 277.43M |
| December 31, 2014 | 289.89M |
| September 30, 2014 | 301.56M |
| June 30, 2014 | 298.42M |
| March 31, 2014 | 193.01M |
| December 31, 2013 | 173.27M |
| September 30, 2013 | 98.78M |
| June 30, 2013 | 107.23M |
| March 31, 2013 | 117.79M |
| December 31, 2012 | 126.48M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
184.01M
Minimum
Dec 2020
622.04M
Maximum
Dec 2022
342.02M
Average
317.56M
Median
Shareholders Equity (Quarterly) Benchmarks
| Mallinckrodt PLC | -- |
| Jazz Pharmaceuticals PLC | 3.086B |
| Nabriva Therapeutics PLC | 25.62M |
| Iterum Therapeutics PLC | 28.00M |
| GH Research PLC | 249.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 758.04M |
| Total Liabilities (Quarterly) | 135.99M |
| Current Ratio | 14.34 |